Therapeutic Advances in Initially Unresectable Locally Advanced Intrahepatic Cholangiocarcinoma: Emerging Treatments and the Role of Liver Transplantation
Current Oncology · 22.05.2025 · 32 (6) · 293
DOI: 10.3390/curroncol32060293 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 22.05.2025. Verfasst von Sofia Lopiano und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Transplant and HPB Surgery, Department of Surgery, Rutgers New Jersey Medical School, Newark, NJ 07103, USA. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Liver Transplantation, Bile Duct Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Optimal curative therapy for intrahepatic cholangiocarcinoma (iCCA) involves hepatic resection; however, due to its insidious nature, iCCA frequently presents at advanced stages. Consequently, 70–80% of patients feature unresectable iCCA at presentation. Recent expansions in therapeutic options for locally advanced unresectable iCCA include immunotherapy, targeted chemotherapeutics, and liver-directed therapies. These have increased progression-free survival, enhanced response rates, and improved downstaging for resection. Liver transplant has also emerged as an alternative for patients whose tumors remain unresectable despite therapeutic response. Here, we explore emerging treatment options included in a multidisciplinary treatment paradigm to prolong survival in patients with initially unresectable locally advanced iCCA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Transplant and HPB Surgery, Department of Surgery, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.
ORCID-Profile: Keri E Lunsford
Förderung
- NIDDK NIH HHS
- NIAID NIH HHS
- NHLBI NIH HHS
- NIH grant funding
Zitieren
APA
Lopiano, S., Guarrera, J. V., & Lunsford, K. E. (2025). Therapeutic Advances in Initially Unresectable Locally Advanced Intrahepatic Cholangiocarcinoma: Emerging Treatments and the Role of Liver Transplantation. Current Oncology, 32(6), 293. https://doi.org/10.3390/curroncol32060293
Vancouver
Lopiano S, Guarrera JV, Lunsford KE. Therapeutic Advances in Initially Unresectable Locally Advanced Intrahepatic Cholangiocarcinoma: Emerging Treatments and the Role of Liver Transplantation. Current Oncology. 2025;32(6):293. doi:10.3390/curroncol32060293
BibTeX
@article{Lopiano2025,
author = {Lopiano, Sofia and Guarrera, James V and Lunsford, Keri E},
title = {Therapeutic Advances in Initially Unresectable Locally Advanced Intrahepatic Cholangiocarcinoma: Emerging Treatments and the Role of Liver Transplantation},
journal = {Current Oncology},
year = {2025},
volume = {32},
number = {6},
pages = {293},
doi = {10.3390/curroncol32060293}
}
EUVIMED